Screening for Nuclear Receptor Activity
Title
Screening for Nuclear Receptor Activity: Indigo Biosciences Looks to Help Pharma Firms Increase Product Pipelines and Diminish Risk
Abstract
Nuclear receptors are popular targets for drug companies searching for new therapeutics for cancer and cardiovascular, metabolic, inflammatory, and other diseases. Indigo Biosciences in State College, PA, designs and sells nuclear receptor assay kits to speed the discovery of new drugs.
